Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 46

Related Articles by Review for PubMed (Select 19328002)

1.

Discovery of dual inhibitors targeting both HIV-1 capsid and human cyclophilin A to inhibit the assembly and uncoating of the viral capsid.

Li J, Tan Z, Tang S, Hewlett I, Pang R, He M, He S, Tian B, Chen K, Yang M.

Bioorg Med Chem. 2009 Apr 15;17(8):3177-88. doi: 10.1016/j.bmc.2009.02.051. Epub 2009 Mar 3.

PMID:
19328002
2.

HIV-1 capsid protein and cyclophilin a as new targets for anti-AIDS therapeutic agents.

Li J, Tang S, Hewlett I, Yang M.

Infect Disord Drug Targets. 2007 Sep;7(3):238-44. Review.

PMID:
17897064
3.

The capsid protein of human immunodeficiency virus: designing inhibitors of capsid assembly.

Neira JL.

FEBS J. 2009 Nov;276(21):6110-7. doi: 10.1111/j.1742-4658.2009.07314.x. Review.

PMID:
19825045
4.

The capsid protein of human immunodeficiency virus: interactions of HIV-1 capsid with host protein factors.

Mascarenhas AP, Musier-Forsyth K.

FEBS J. 2009 Nov;276(21):6118-27. doi: 10.1111/j.1742-4658.2009.07315.x. Review.

PMID:
19825046
5.

[Assembly and maturation of HIV-1--targets for new anti-HIV compounds].

Bukrinskaia AG, Vorkunova GK, Burshteĭn ME.

Mol Gen Mikrobiol Virusol. 2005;(1):18-23. Review. Russian.

PMID:
15790028
6.

HIV type 1 integrase inhibitors: from basic research to clinical implications.

Jegede O, Babu J, Di Santo R, McColl DJ, Weber J, Quiñones-Mateu M.

AIDS Rev. 2008 Jul-Sep;10(3):172-89. Review.

PMID:
18820719
7.

New approaches for antiviral targeting of HIV assembly.

Prevelige PE Jr.

J Mol Biol. 2011 Jul 22;410(4):634-40. doi: 10.1016/j.jmb.2011.03.074. Review.

8.

The capsid protein of human immunodeficiency virus: intersubunit interactions during virus assembly.

Mateu MG.

FEBS J. 2009 Nov;276(21):6098-109. doi: 10.1111/j.1742-4658.2009.07313.x. Review.

PMID:
19825044
9.

Cyclophilin, TRIM5, and innate immunity to HIV-1.

Sokolskaja E, Luban J.

Curr Opin Microbiol. 2006 Aug;9(4):404-8. Epub 2006 Jul 3. Review.

PMID:
16815734
10.
11.
12.

The HIV-1 capsid protein as a drug target: recent advances and future prospects.

Domenech R, Neira JL.

Curr Protein Pept Sci. 2013 Dec;14(8):658-68. Review.

PMID:
24106962
13.

Capsid (CA) protein as a novel drug target: recent progress in the research of HIV-1 CA inhibitors.

Zhang J, Liu X, De Clercq E.

Mini Rev Med Chem. 2009 Apr;9(4):510-8. Review.

PMID:
19356128
14.

Molecular recognition in the human immunodeficiency virus capsid and antiviral design.

Bocanegra R, Rodríguez-Huete A, Fuertes MÁ, Del Álamo M, Mateu MG.

Virus Res. 2012 Nov;169(2):388-410. doi: 10.1016/j.virusres.2012.06.016. Epub 2012 Jun 21. Review.

PMID:
22728445
15.

Identification of HIV inhibitors guided by free energy perturbation calculations.

Acevedo O, Ambrose Z, Flaherty PT, Aamer H, Jain P, Sambasivarao SV.

Curr Pharm Des. 2012;18(9):1199-216. Review.

16.

HIV-1 assembly and budding as targets for drug discovery.

Li F, Wild C.

Curr Opin Investig Drugs. 2005 Feb;6(2):148-54. Review.

PMID:
15751737
17.

Cyclophilin A: potential functions and therapeutic target for human cancer.

Obchoei S, Wongkhan S, Wongkham C, Li M, Yao Q, Chen C.

Med Sci Monit. 2009 Nov;15(11):RA221-32. Review.

PMID:
19865066
18.

Crystal structures of cyclophilin and its partners.

Ke H, Huai Q.

Front Biosci. 2004 Sep 1;9:2285-96. Review.

PMID:
15353287
19.

Peptide inhibition of HIV-1: current status and future potential.

Kaushik-Basu N, Basu A, Harris D.

BioDrugs. 2008;22(3):161-75. Review.

PMID:
18481899
20.

Capsid proteins of enveloped viruses as antiviral drug targets.

Klumpp K, Crépin T.

Curr Opin Virol. 2014 Apr;5:63-71. doi: 10.1016/j.coviro.2014.02.002. Epub 2014 Mar 5. Review.

PMID:
24607800
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk